Drugs that contain Edoxaban Tosylate
1. List of Savaysa drug patents
SAVAYSA's oppositions filed in EPO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7365205 | DAIICHI SANKYO INC | Diamine derivatives |
Apr, 2027
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9149532 | DAIICHI SANKYO INC | Pharmaceutical composition |
Mar, 2028
(4 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| M (M) | Aug 9, 2022 |
Market Authorisation Date: 08 January, 2015
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of SAVAYSA before it's patent expiration?
More Information on Dosage
SAVAYSA family patents
15
Japan
11
United States
4
South Africa
4
Mexico
4
Norway
4
Poland
4
China
4
European Union
3
Israel
3
Australia
3
Russia
3
Brazil
3
Spain
3
Korea, Republic of
3
Canada
2
Denmark
2
Hong Kong
2
Lithuania
2
Hungary
2
Argentina
2
Portugal
2
Cyprus
2
Malaysia
2
Taiwan, Province of China
2
New Zealand
1
Austria
1
Belgium
1
Slovenia
1
Philippines
1
Colombia
1
Croatia
1
Singapore
1
Netherlands
1
Luxembourg
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic